Statistics and Modeling in Response to COVID-19 at NIAID
Dr. Dean Follmann, Chief of the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases (NIAID)
The COVID-19 pandemic is an enormous public health challenge which requires an extraordinary response. At the National Institute of Allergy and Infectious Diseases, statisticians have been deeply involved in crafting and executing research to better understand, treat and prevent COVID-19. This talk will focus on the statistical aspects of different current projects including design of vaccine trials, issues in constructing running platform treatment trials, epidemiologic modeling, and the role of the immune response in modulating vaccine efficacy.
About the Speaker
Dean Follmann is Chief of the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases (NIAID), a role he has held for the past 16 years. He has authored or co-authored more than 250 peer-reviewed research articles and received numerous awards, including the Department of Health and Human Services Secretary’s Award for Distinguished Service, the Best Paper in Biometrics 2009, and is an elected Fellow of the American Statistical Association in 2003. He serves on committees and advisory boards for the US Food and Drug Administration, the National Institutes of Health, and academic departments. Current research interests focus on statistical methods related to vaccinology.